December 20, 2012

HELIX BIOPHARMA ANNOUNCES APPOINTMENT OF DIRECTOR (PDF)

(Aurora, Ontario) – Helix BioPharma Corp. (TSX, FSE: “HBP”), a biopharmaceutical company developing 
drug candidates for the prevention and treatment of cancer, today announced the appointment of John A. 
Rogers to the board of directors. Mr. Rogers’s appointment was effective December 18, 2012.